Does RILONACEPT Cause Product dose omission issue? 94 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Product dose omission issue have been filed in association with RILONACEPT (Arcalyst). This represents 11.2% of all adverse event reports for RILONACEPT.
94
Reports of Product dose omission issue with RILONACEPT
11.2%
of all RILONACEPT reports
0
Deaths
5
Hospitalizations
How Dangerous Is Product dose omission issue From RILONACEPT?
Of the 94 reports, 5 (5.3%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RILONACEPT. However, 94 reports have been filed with the FAERS database.
What Other Side Effects Does RILONACEPT Cause?
Injection site erythema (112)
Chest pain (98)
Injection site pain (73)
Fatigue (70)
Off label use (63)
Pain (63)
Injection site pruritus (57)
Injection site rash (57)
Pericarditis (57)
Dyspnoea (53)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which RILONACEPT Alternatives Have Lower Product dose omission issue Risk?
RILONACEPT vs RILPIVIRINE
RILONACEPT vs RILUZOLE
RILONACEPT vs RIMABOTULINUMTOXINB
RILONACEPT vs RIMEGEPANT
RILONACEPT vs RIOCIGUAT